beta-cel cytoadher lymphocyt subject risk type insulin-depend progress diabet year increas bind vitro t-lymphocyt type insulin-depend diabet patient beta-cel membran antigen lymphocyt control subject marker cell-medi immun diabet rosett present studi diabet rosett subject risk type diabet first degre rel type diabet patient nondiabet subject previou transient hyperglycaemia mean number lymphocyt adher beta-cel beta-cl subject risk type diabet age- sex-match control blood bank donor number beta-cl type diabet patient subject risk one-way analysi varianc rank kruskal-w popul control diabet risk subject differ term beta-cl valu percentag subject risk posit test beta-cl valu percentil control differ subgroup subject risk term mean sem beta-cl percentag individu posit test diabet rosett acut insulin respons percentil control immunoreact insulin min pmol/l chi hla DR heterozygos chi islet cell antibodi regardless threshold posit juvenil diabet foundat unit insulin autoantibodi hla dr+ sex statist associ hla DR heterozygos low acut insulin respons glucos chi preliminari longitudin follow-up islet cell antibody-posit subject diabet beta-cl valu percentil control diabet rosett individu risk type diabet marker cell-medi immun 